Searched for
USFDA ON CIPLA
Cipla recalls over 400 cartons of cancer drug in US: FDACipla USA is recalling over 400 cartons of its anti-cancer drug Nilotinib Capsules. The recall is due to a manufacturing issue where the ca...08 Mar, 2026, 11.16 AM IST- Cipla shares slide 5% after temporary halt in key drug manufacturingCipla shares fell sharply on Friday after a halt in Lanreotide Injection production due to USFDA observations at its Greek partner. Supply ...16 Jan, 2026, 10.06 AM IST
- Cipla shares in focus after Goa facility receives form 483 with one observation from USFDACipla share price has risen by 10% over the past 12 months and 64% over the last three years. The company's current market capitalization i...21 Jan, 2025, 09.27 AM IST
- USFDA issues Form 483 with 1 inspectional observation to Cipla's Kurkumbh unitA routine current Good Manufacturing Practices (cGMP) inspection was conducted by the USFDA at the company's manufacturing facility at Kurk...08 May, 2024, 03.56 PM IST
- Cipla slumps nearly 8% after USFDA warning letter for manufacturing lapsesAfter an inspection at the Pithampur plant, the USFDA issued a warning letter stating that the company's methods, facilities, or controls f...23 Nov, 2023, 03.13 PM IST
- USFDA warns Cipla for lapses in manufacturing practices at Pithampur facilityAccording to an exchange filing, the drug manufacturer was given a detailed breakdown of the lapses in methods followed at the facility by ...20 Nov, 2023, 08.30 AM IST
- Dr Reddy's, Cipla, Aurobindo units recall products in US marketAs per the enforcement report by the US Food and Drug Administration (USFDA), the US-based unit of Dr Reddy's Laboratories is recalling 2,8...23 Oct, 2022, 11.14 AM IST
- Glenmark, Strides Pharma, Cipla recall products in the USThe USFDA noted in its report that the company, a subsidiary of Mumbai-based drug firm, is recalling the affected lot due to "blister packa...21 Aug, 2022, 11.25 AM IST
- Cipla gains 3% on USFDA nod to market Lanreotide"This approval is a significant step for our US business and is in line with our aspiration to continue growth in our complex product pipel...20 Dec, 2021, 10.50 AM IST
- Cipla recalls 7,228 bottles of overactive bladder treatment drug in AmericaAs per the USFDA, a class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or...25 Jul, 2021, 12.27 PM IST
- Cipla gets USFDA nod for migraine drugThe newly approved product is a generic therapeutic equivalent version of GlaxoSmithKline's Imitrex Nasal Spray.02 Mar, 2021, 11.16 AM IST
- Cipla launches generic remdesivir for coronavirus patientsThe USFDA had issued an Emergency Use Authorization (EUA) to Gilead Sciences Inc for emergency use of remdesivir for the treatment of coron...22 Jun, 2020, 09.38 AM IST
- USFDA issues warning letter to Cipla for Goa manufacturing facilityDrug firm Cipla Ltd said that the US health regulator has issued a warning letter to the company for its manufacturing facility in Goa. The...26 Feb, 2020, 11.38 AM IST
- Cipla gets USFDA nod for overactive bladder treating drug"We have received final approval for ANDA for Darifenacin extended-release tablets, 7.5 mg and 15mg, from USFDA," a company statement said ...02 Sep, 2016, 04.52 PM IST
- Cipla's Indore plant under USFDA scanner over norms violationsAccording to reports, USFDA had sent letter to the company after its officials conducted inspection of the Indore plant between July and Au...20 Oct, 2015, 07.12 PM IST
- Cipla gets USFDA nod for Lopinavir, Ritonavir oral pelletsCipla has received approval from US health regulator USFDA for Lopinavir and Ritonavir oral pellets used for treating AIDS in infants and y...03 Jun, 2015, 06.01 PM IST
- USFDA clears Cipla's facilitiesCipla has successfully addressed all the nine manufacturing deficiencies pointed out by the US Food and Drug Administration (FDA) at its Ba...31 Aug, 2009, 12.34 AM IST
Load More
